JDOC Holdings — JPMorgan Healthcare Leaders ETF
All 66 reported holdings of JPMorgan Healthcare Leaders ETF (JDOC) by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets | Value (USD) |
|---|---|---|
| Eli Lilly & Co. | 6.81% | $757.96K |
| AbbVie, Inc. | 6.58% | $732.01K |
| Johnson & Johnson | 6.20% | $689.78K |
| UnitedHealth Group, Inc. | 5.83% | $648.71K |
| AstraZeneca plc | 4.57% | $507.89K |
| Merck & Co., Inc. | 4.21% | $468.27K |
| Bristol-Myers Squibb Co. | 3.50% | $389.41K |
| Thermo Fisher Scientific, Inc. | 3.19% | $354.43K |
| Intuitive Surgical, Inc. | 2.96% | $329.02K |
| CVS Health Corp. | 2.71% | $301.34K |
| Novo Nordisk A/S | 2.65% | $295.33K |
| Roche Holding AG | 2.65% | $294.62K |
| Hoya Corp. | 2.35% | $261.44K |
| Regeneron Pharmaceuticals, Inc. | 2.19% | $243.23K |
| Boston Scientific Corp. | 2.04% | $227.33K |
| Ucb SA | 1.97% | $218.65K |
| Vertex Pharmaceuticals, Inc. | 1.96% | $217.96K |
| Danaher Corp. | 1.90% | $211.88K |
| Edwards Lifesciences Corp. | 1.83% | $203.32K |
| McKesson Corp. | 1.78% | $198.09K |
| Stryker Corp. | 1.59% | $177.10K |
| Argenx SE | 1.54% | $170.96K |
| Teva Pharmaceutical Industries Ltd. | 1.41% | $156.99K |
| Cardinal Health, Inc. | 1.38% | $153.53K |
| Centene Corp. | 1.32% | $147.06K |
| Biogen, Inc. | 1.30% | $144.61K |
| Zoetis, Inc. | 1.17% | $130.61K |
| United Therapeutics Corp. | 1.16% | $129.13K |
| Lonza Group AG | 1.11% | $122.96K |
| Novartis AG | 1.04% | $115.72K |
| Fresenius SE & Co. KGaA | 1.04% | $115.41K |
| IQVIA Holdings, Inc. | 1.03% | $114.98K |
| Sartorius AG | 0.91% | $101.68K |
| Spyre Therapeutics, Inc. | 0.89% | $98.80K |
| Apogee Therapeutics, Inc. | 0.86% | $95.49K |
| Ionis Pharmaceuticals, Inc. | 0.84% | $93.97K |
| Argenx SE | 0.82% | $90.97K |
| CG oncology, Inc. | 0.78% | $87.03K |
| Ascendis Pharma A/S | 0.71% | $78.68K |
| Align Technology, Inc. | 0.69% | $76.92K |
| Immunome, Inc. | 0.69% | $76.87K |
| Dyne Therapeutics, Inc. | 0.67% | $74.87K |
| JPMorgan Securities Lending Money Market Fund | 0.64% | $71.31K |
| Dexcom, Inc. | 0.64% | $71.22K |
| Neurocrine Biosciences, Inc. | 0.63% | $70.18K |
| Genmab A/S | 0.63% | $70.17K |
| Daiichi Sankyo Co. Ltd. | 0.61% | $68.23K |
| Convatec Group plc | 0.61% | $67.34K |
| Cigna Group (The) | 0.60% | $67.12K |
| Medtronic plc | 0.59% | $65.42K |
| Alumis, Inc. | 0.54% | $60.39K |
| Nuvalent, Inc. | 0.53% | $58.56K |
| Bio-Techne Corp. | 0.42% | $46.63K |
| Sionna Therapeutics, Inc. | 0.42% | $46.48K |
| Disc Medicine, Inc. | 0.38% | $41.94K |
| Alnylam Pharmaceuticals, Inc. | 0.31% | $34.66K |
| Viridian Therapeutics, Inc. | 0.28% | $31.31K |
| Evommune, Inc. | 0.27% | $29.99K |
| Xenon Pharmaceuticals, Inc. | 0.27% | $29.98K |
| HCA Healthcare, Inc. | 0.27% | $29.54K |
| Genmab A/S | 0.12% | $13.87K |
| Danish Krone | 0.00% | $0 |
| Euro | 0.00% | $-1 |
| Japanese Yen | 0.00% | $-0 |
| Swiss Franc | 0.00% | $0 |
| British Pound | 0.00% | $-0 |
JDOC overview: performance, fees, allocation and SEC filings